Real-life experience of secondary prophylaxis with DOACs in splanchnic venous thrombosis during COVID-19 pandemic

Guarnera, Luca; Buzzatti, Elisa; Bonanni, F; Paterno, Giovangiacinto; Riccitelli, Antonella; Forte, Vittorio; Venditti, Adriano; Principe, Maria Ilaria Del

doi:10.1007/s00277-023-05184-8

Ann Hematol

2023

DOI: 10.1007/s00277-023-05184-8

|View full text |Cite

Real-life experience of secondary prophylaxis with DOACs in splanchnic venous thrombosis during COVID-19 pandemic

Luca Guarnera

Elisa Buzzatti

F Bonanni

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Thrombosis in Myeloid Malignancies: From CHIP to AML

Borsellino,

Bravo-Perez,

Visconte

et al. 2024

CHDDT

View full text Add to dashboard Cite

The development of myeloid malignancies is a multi-step process starting from pre-malignant stages. Large-scale studies on clonal hematopoiesis of indeterminate potential (CHIP) identified this condition as a risk factor for developing hematologic malignancies, in particular myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). In parallel, CHIP was found to confer an enhanced thrombotic risk, in particular for cardiovascular diseases. In a similar fashion, in recent years, alongside their life-threatening features, increasing attention has been drawn toward thrombotic complications in myeloid malignancies. Thus, the purpose of this review is to gather a growing body of evidence on incidence, pathogenesis and clinical impact of thrombosis in myeloid malignancies at every step of malignant progression, from CHIP to AML.

show abstract

Thrombosis in Myeloid Malignancies: From CHIP to AML

Borsellino,

Bravo-Perez,

Visconte

et al. 2024

CHDDT

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Real-life experience of secondary prophylaxis with DOACs in splanchnic venous thrombosis during COVID-19 pandemic

Cited by 1 publication

References 5 publications

Thrombosis in Myeloid Malignancies: From CHIP to AML

Thrombosis in Myeloid Malignancies: From CHIP to AML

Contact Info

Product

Resources

About